Detalles de la búsqueda
1.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029412
2.
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Cancer
; 123(14): 2688-2697, 2017 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28334439
3.
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
J Clin Oncol
; 41(2): 186-197, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166727
4.
The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote.
J Cancer Surviv
; 16(3): 542-551, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34018096
5.
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort.
Cancer
; 117(22): 5067-73, 2011 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21681734
6.
Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis.
J Immunother Cancer
; 9(5)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963015
7.
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial.
Clin Cancer Res
; 26(12): 3024-3034, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32071117
8.
Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609.
J Clin Oncol
; 38(6): 567-575, 2020 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31880964
9.
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697).
Clin Cancer Res
; 23(17): 5034-5043, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28536308
10.
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697).
J Clin Oncol
; 35(8): 885-892, 2017 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28135150
11.
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers.
J Clin Oncol
; 20(9): 2251-66, 2002 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11980996
12.
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697).
J Clin Oncol
; 33(34): 4066-76, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26351350
13.
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
J Clin Oncol
; 27(1): 127-45, 2009 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19018081
14.
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group.
J Clin Oncol
; 26(35): 5748-54, 2008 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19001327
15.
Clinical research by community oncologists.
CA Cancer J Clin
; 53(2): 73-81, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12691265
Resultados
1 -
15
de 15
1
Próxima >
>>